Transplant tolerance: New insights and strategies for long-term allograft acceptance

Paulina Ruiz, Paula Maldonado, Yessia Hidalgo, Alejandra Gleisner, Daniela Sauma, Cinthia Silva, Juan Jose Saez, Sarah Nuñez, Mario Rosemblatt, Maria Rosa Bono

Resultado de la investigación: Review article

26 Citas (Scopus)

Resumen

One of the greatest advances in medicine during the past century is the introduction of organ transplantation. This therapeutic strategy designed to treat organ failure and organ dysfunction allows to prolong the survival of many patients that are faced with no other treatment option. Today, organ transplantation between genetically dissimilar individuals (allogeneic grafting) is a procedure widely used as a therapeutic alternative in cases of organ failure, hematological disease treatment, and some malignancies. Despite the potential of organ transplantation, the administration of immunosuppressive drugs required for allograft acceptance induces severe immunosuppression in transplanted patients, which leads to serious side effects such as infection with opportunistic pathogens and the occurrence of neoplasias, in addition to the known intrinsic toxicity of these drugs. To solve this setback in allotransplantation, researchers have focused on manipulating the immune response in order to create a state of tolerance rather than unspecific immunosuppression. Here, we describe the different treatments and some of the novel immunotherapeutic strategies undertaken to induce transplantation tolerance.

Idioma originalEnglish
Número de artículo210506
PublicaciónClinical and Developmental Immunology
Volumen2013
DOI
EstadoPublished - 2013

Huella dactilar

Allografts
Transplants
Organ Transplantation
Immunosuppression
Transplantation Tolerance
Therapeutics
Hematologic Diseases
Opportunistic Infections
Immunosuppressive Agents
Drug-Related Side Effects and Adverse Reactions
Neoplasms
Research Personnel
Medicine
Survival
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Medicine(all)

Citar esto

Ruiz, P., Maldonado, P., Hidalgo, Y., Gleisner, A., Sauma, D., Silva, C., ... Bono, M. R. (2013). Transplant tolerance: New insights and strategies for long-term allograft acceptance. Clinical and Developmental Immunology, 2013, [210506]. https://doi.org/10.1155/2013/210506
Ruiz, Paulina ; Maldonado, Paula ; Hidalgo, Yessia ; Gleisner, Alejandra ; Sauma, Daniela ; Silva, Cinthia ; Saez, Juan Jose ; Nuñez, Sarah ; Rosemblatt, Mario ; Bono, Maria Rosa. / Transplant tolerance : New insights and strategies for long-term allograft acceptance. En: Clinical and Developmental Immunology. 2013 ; Vol. 2013.
@article{74f08d9073424d4192a8559c32332777,
title = "Transplant tolerance: New insights and strategies for long-term allograft acceptance",
abstract = "One of the greatest advances in medicine during the past century is the introduction of organ transplantation. This therapeutic strategy designed to treat organ failure and organ dysfunction allows to prolong the survival of many patients that are faced with no other treatment option. Today, organ transplantation between genetically dissimilar individuals (allogeneic grafting) is a procedure widely used as a therapeutic alternative in cases of organ failure, hematological disease treatment, and some malignancies. Despite the potential of organ transplantation, the administration of immunosuppressive drugs required for allograft acceptance induces severe immunosuppression in transplanted patients, which leads to serious side effects such as infection with opportunistic pathogens and the occurrence of neoplasias, in addition to the known intrinsic toxicity of these drugs. To solve this setback in allotransplantation, researchers have focused on manipulating the immune response in order to create a state of tolerance rather than unspecific immunosuppression. Here, we describe the different treatments and some of the novel immunotherapeutic strategies undertaken to induce transplantation tolerance.",
author = "Paulina Ruiz and Paula Maldonado and Yessia Hidalgo and Alejandra Gleisner and Daniela Sauma and Cinthia Silva and Saez, {Juan Jose} and Sarah Nu{\~n}ez and Mario Rosemblatt and Bono, {Maria Rosa}",
year = "2013",
doi = "10.1155/2013/210506",
language = "English",
volume = "2013",
journal = "Journal of Immunology Research",
issn = "2314-8861",
publisher = "Hindawi Publishing Corporation",

}

Ruiz, P, Maldonado, P, Hidalgo, Y, Gleisner, A, Sauma, D, Silva, C, Saez, JJ, Nuñez, S, Rosemblatt, M & Bono, MR 2013, 'Transplant tolerance: New insights and strategies for long-term allograft acceptance', Clinical and Developmental Immunology, vol. 2013, 210506. https://doi.org/10.1155/2013/210506

Transplant tolerance : New insights and strategies for long-term allograft acceptance. / Ruiz, Paulina; Maldonado, Paula; Hidalgo, Yessia; Gleisner, Alejandra; Sauma, Daniela; Silva, Cinthia; Saez, Juan Jose; Nuñez, Sarah; Rosemblatt, Mario; Bono, Maria Rosa.

En: Clinical and Developmental Immunology, Vol. 2013, 210506, 2013.

Resultado de la investigación: Review article

TY - JOUR

T1 - Transplant tolerance

T2 - New insights and strategies for long-term allograft acceptance

AU - Ruiz, Paulina

AU - Maldonado, Paula

AU - Hidalgo, Yessia

AU - Gleisner, Alejandra

AU - Sauma, Daniela

AU - Silva, Cinthia

AU - Saez, Juan Jose

AU - Nuñez, Sarah

AU - Rosemblatt, Mario

AU - Bono, Maria Rosa

PY - 2013

Y1 - 2013

N2 - One of the greatest advances in medicine during the past century is the introduction of organ transplantation. This therapeutic strategy designed to treat organ failure and organ dysfunction allows to prolong the survival of many patients that are faced with no other treatment option. Today, organ transplantation between genetically dissimilar individuals (allogeneic grafting) is a procedure widely used as a therapeutic alternative in cases of organ failure, hematological disease treatment, and some malignancies. Despite the potential of organ transplantation, the administration of immunosuppressive drugs required for allograft acceptance induces severe immunosuppression in transplanted patients, which leads to serious side effects such as infection with opportunistic pathogens and the occurrence of neoplasias, in addition to the known intrinsic toxicity of these drugs. To solve this setback in allotransplantation, researchers have focused on manipulating the immune response in order to create a state of tolerance rather than unspecific immunosuppression. Here, we describe the different treatments and some of the novel immunotherapeutic strategies undertaken to induce transplantation tolerance.

AB - One of the greatest advances in medicine during the past century is the introduction of organ transplantation. This therapeutic strategy designed to treat organ failure and organ dysfunction allows to prolong the survival of many patients that are faced with no other treatment option. Today, organ transplantation between genetically dissimilar individuals (allogeneic grafting) is a procedure widely used as a therapeutic alternative in cases of organ failure, hematological disease treatment, and some malignancies. Despite the potential of organ transplantation, the administration of immunosuppressive drugs required for allograft acceptance induces severe immunosuppression in transplanted patients, which leads to serious side effects such as infection with opportunistic pathogens and the occurrence of neoplasias, in addition to the known intrinsic toxicity of these drugs. To solve this setback in allotransplantation, researchers have focused on manipulating the immune response in order to create a state of tolerance rather than unspecific immunosuppression. Here, we describe the different treatments and some of the novel immunotherapeutic strategies undertaken to induce transplantation tolerance.

UR - http://www.scopus.com/inward/record.url?scp=84878645678&partnerID=8YFLogxK

U2 - 10.1155/2013/210506

DO - 10.1155/2013/210506

M3 - Review article

C2 - 23762087

AN - SCOPUS:84878645678

VL - 2013

JO - Journal of Immunology Research

JF - Journal of Immunology Research

SN - 2314-8861

M1 - 210506

ER -